Ipamorelin
Selective GH secretagogueExamined in selective growth-hormone release models.
← Catalog · research summary
CJC-1295
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone, modified to stay in circulation longer.
- CLASS
- Long-acting GHRH analog
- FORM
- Lyophilized powder
- PAPERWORK
- Certificate of analysis provided with every batch
- STORAGE
- −20 °C, dry, away from light
What it is
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone, modified to stay in circulation longer.
What labs have examined
Researchers have examined CJC-1295 in GHRH signaling research. Published work includes:
- Extended GH and IGF-1 signaling in pharmacology studies
- Pulsatile GH release in lab research
- Frequently examined alongside GH secretagogues like ipamorelin
GH Signaling
Compounds that act on the growth-hormone pathway, examined for how they influence GH release in lab models.
This page summarizes published laboratory and animal (preclinical) research for educational purposes only. It is not a claim of safety or effectiveness in people. CJC-1295 from HelixPulse Peptides will be sold strictly for in-vitro laboratory research. Not evaluated by the FDA. Not for human or animal consumption, and not intended to diagnose, treat, cure or prevent any disease.
Same research area
Sermorelin
GHRH 1–29 analogExamined in pituitary GH-signaling research.